What 20 Years of Peptide Use Taught Me (Most Experts Won't Say This)

What 20 Years of Peptide Use Taught Me (Most Experts Won't Say This)

From Muscle Intelligence by Ben Pakulski

March 23, 2026 · 51 min

About this episode

Ben Pakulski discusses the implications of peptide use and safety in healthcare.

Want the FULL deep dive on peptides? Join my exclusive peptide webinar and get the complete 2026 Peptide Reference Guide https://checkout.muscleintelligence.com/peptides Peptides are the future of healthcare — but what no one is telling you could be putting your health at risk. In this episode of the Muscle Intelligence Podcast, Ben Pakulski breaks down the entire 2026 peptide landscape, including the FDA status of 19 commonly used peptides, RFK Jr.'s recent announcement on Joe Rogan about reclassifying some common peptides, and why buying research-grade peptides from China could expose you to dangerous toxins hidden in that "99% pure" vial you're injecting. Ben walks through all 9 categories of peptides — from GH secretagogues like CJC-1295, ipamorelin, and sermorelin, to tissue repair peptides like BPC-157, TB-500, and GHK-Cu, to mitochondrial and longevity peptides like SS31 — explaining the critical difference between pharmaceutical-grade, compounding pharmacy products, and research-use-only sourcing. Whether you're exploring peptides for fat loss, muscle building, injury recovery, anti-aging, or brain optimization, this episode gives you the no-BS, science-backed framework…

People in this episode

Host: Ben Pakulski

Topics covered

  • peptides
  • healthcare
  • safety
  • muscle building
  • anti-aging
  • fat loss

Keywords

  • peptides
  • health
  • FDA
  • muscle building
  • anti-aging
  • safety
  • purity testing

Mentioned in this episode

Organizations: FDA

Products: CJC-1295, ipamorelin, sermorelin, BPC-157, TB-500, GHK-Cu, SS31

More episodes of Muscle Intelligence

Explore listener stats, chart rankings, contacts and more on the Muscle Intelligence podcast page.